Nanostructure Coating Precursors for High-Purity PEG Surface Layers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing polymer coatings for nanostructures, such as PEG-containing coatings, face issues with impurities during large-scale production, leading to increased production costs and potential quality degradation of the final pharmaceutical product.
Innovation Solution
Development of compounds with hydrophilic polymer groups, such as PEG chains, that form a stable coating on nanostructures without the need for additional purification steps, ensuring high purity and cost-effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PEG-containing polymer coatings are used to prevent aggregation and improve biocompatibility of nanostructures, then biocompatibility and stability are improved, but impurities arise during large scale production increasing costs and potentially degrading product quality
Solution Approach 1:
The coating precursor is divided into distinct functional segments: a hydrophilic polymer segment (PEG chain with 10-200 units) for biocompatibility and an organometallic segment (rhenium or technetium carbonyl cluster) for controlled decomposition. This segmentation allows each part to perform its specific function independently, with the polymer providing steric stabilization and the organometallic part decomposing to release CO and leave a clean metal surface, thereby preventing impurity formation while maintaining biocompatibility.
Solution Approach 2:
The hydrophilic polymer coating is applied to the nanostructure surface before the radiopharmaceutical active ingredient is attached. This preliminary coating action creates a stable, biocompatible foundation that prevents aggregation and provides a controlled surface for subsequent functionalization, ensuring that the final product maintains both stability and purity throughout the production process.
2Manufacturing precision
If multiple purification steps are implemented to remove impurities from PEG-coated nanostructures, then product quality is improved, but production costs increase and production time is extended
Solution Approach 1:
The harmful impurities (carbon monoxide and carbon dioxide) are extracted from the system through controlled decomposition of the organometallic coating precursor. The PEG-stabilized nanostructures allow for selective removal of decomposition products while retaining the desired coating and active ingredient, thereby achieving high purity without requiring multiple complex purification steps and maintaining production efficiency.
3Duration of action of moving object
If the circulation time of nanostructures in blood is extended, then sufficient time for cell binding in targeted tissues is achieved, but stability requirements become more stringent
Solution Approach 1:
A composite coating structure is formed by combining a hydrophilic polymer (PEG) with an organometallic compound (rhenium or technetium carbonyl cluster). The PEG component provides extended circulation time through steric stabilization and reduced protein adsorption, while the organometallic component enhances stability through strong surface binding and controlled decomposition kinetics, creating a synergistic effect that achieves both prolonged circulation and enhanced stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds provide extended circulation time in the blood, improved stability, and enhanced biocompatibility, reducing production costs and maintaining the quality of the coated nanostructures.
Implementation Method 1
Poly1 and Poly2 independently are selected from the group consisting of a hydrogen and a hydrophilic polymer group having a molecular weight of 400 to 10 000 Da
Implementation Method 2
These compounds (also referred to as coating precursors) can be applied as a layer on nanostructure surfaces
Data Source
AI summary
The present disclosure relates to a compound according to Formula (I) and to a method for producing the compound as well as to the use of the compound as an intermediate in the production of coated nanostructures. The present disclosure also relates to such nanostructures and to the use of such nanostructures as carriers of radionuclides as well as pharmaceutical compositions comprising such nanostructures.